Compare Amgen, Inc. (AMGN) vs FuelCell Energy Inc (FCEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amgen, Inc. vs FuelCell Energy Inc — how do they compare? Amgen, Inc. trades at $356 (market cap $196.12B), while FuelCell Energy Inc trades at $20.06 (market cap $1.68B). The key difference: Amgen, Inc. is far larger — about 116.7× FuelCell Energy Inc's market cap, and Amgen, Inc. pays a 2.77% dividend while FuelCell Energy Inc pays none. Which is the better fit depends on your goals.
| AMGN | FCEL | |
|---|---|---|
Market Cap | $196.12B | $1.68B |
Sector | Health | Industrials |
52-Week High | $388.16 | $36.01 |
52-Week Low | $271.18 | $3.92 |
Enterprise Value | $241.41B | $1.53B |
Dividend Yield | 2.77% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.
The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.
FuelCell Energy (FCEL) trades at $21.03, down 8.57% amid recent volatility from a $225 million stock offering. The stock shows a bullish technical signal with moving averages supporting an uptrend, while oscillators remain neutral. Fundamentally, the company continues to report losses with a net income margin of -132.41% in 2025, though revenue grew to $158.16 million. Recent news highlights a strategic partnership with Siemens to scale clean power solutions for data centers, a key growth area representing 90% of its sales pipeline.
FCEL presents a high-risk, high-reward opportunity driven by AI data center demand and new partnerships, but persistent profitability challenges and shareholder dilution from recent financing pose significant risks. Analyst consensus is mixed with a $20.13 price target, suggesting cautious optimism amid ongoing operational losses and competitive pressures in the fuel cell sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About FuelCell Energy Inc
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products, which efficiently convert chemical energy in fuels into electricity through a series of chemical reactions. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.
Read more on FCEL →
